Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981407 · ClinicalTrials.gov registry record · Phase 3
Myocardial Ischemia and Transfusion
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,506
- Enrollment target
NCT02981407 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 3,506 participants.
The verdict
NCT02981407, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,506 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.
Interventions
- BIOLOGICAL Red Blood Cell Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,506 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2023-10-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02981407
The ClinicalTrials.gov registry entry for NCT02981407 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,506 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red Blood Cell Transfusion is the first listed.
NCT02981407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02981407 about?
NCT02981407 is a clinical study titled "Myocardial Ischemia and Transfusion". The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.
What is the current status of trial NCT02981407?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,506 participants. The study started on 2017-04-25. Estimated completion is 2023-10-20.
What interventions are being tested in trial NCT02981407?
The interventions under investigation include: Red Blood Cell Transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT02981407?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.